Macrolides for the Treatment of Chronic Sinusitis, Asthma, and COPD
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthmaAnnals of Allergy, Asthma & Immunology, 2000
- Impact of endoscopic sinus surgery on global health perception: An outcomes studyOtolaryngology–Head and Neck Surgery, 1998
- Evidence for Chlamydia pneumoniae Infection in Steroid-Dependent AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Myeloperoxidase and interleukin-8 levels in chronic sinusitisClinical & Experimental Allergy, 1997
- Effects of Long-Term Low-Dose Macrolide Administration on Neutrophil Recruitment and IL-8 in the Nasal Discharge of Chronic Sinusitis Patients.The Tohoku Journal of Experimental Medicine, 1997
- The Macrolide Antibacterial Roxithromycin Reduces Bronchial Hyperresponsiveness and Superoxide Anion Production by Polymorphonuclear Leukocytes in Patients with AsthmaJournal of Asthma, 1995
- Troleandomycin in the treatment of difficult asthmaJournal of Allergy and Clinical Immunology, 1993
- Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthmaJournal of Allergy and Clinical Immunology, 1993
- Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin againstMycoplasma pneumoniae, Mycoplasma hominis andUreaplasma urealyticumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthmaJournal of Allergy and Clinical Immunology, 1986